Immunology | Oncology Prediction of IDO1 Inhibitors by a Fingerprint-based Stacking Ensemble Model Named IDO1Stack. June 21, 2023
Drug Discovery | Oncology Novel 1,2,3-Triazole Erlotinib Derivatives as Potent IDO1 Inhibitors: Design, Drug-Target Interactions Prediction, Synthesis, Biological Evaluation, Molecular Docking and ADME Properties Studies. June 9, 2022